SCHEMBL8388486

SCHEMBL8388486

Cc1cc(CC(=O)O)c(O)c2c1c1ccccc1n2Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 2/20 0.45
MAPK1 P28482 2/20 0.45
MAPT P10636 1/20 0.45
EGLN1 Q9GZT9 2/20 0.45
PLA2G2A P14555 4/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.44
PLA2G1B P04054 1/20 0.44
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
FOLH1 Q04609 1/20 0.42
CYP19A1 P11511 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27471973 0.89 MAPT (0.45) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL8390508 0.85 THRB (0.46) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL8387036 0.85 MEN1 (0.48) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL8387525 0.85 PLA2G2A (0.49) MEN1KMT2AALDH1A1SMN1; SMN2MAPK1
SCHEMBL8388364 0.84 PTGDR2 (0.51) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL8388323 0.84 MEN1 (0.44) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL8388869 0.84 MEN1 (0.44) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL8388054 0.83 MEN1 (0.43) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL8388247 0.82 MEN1 (0.42) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL8388463 0.82 PLA2G2A (0.43) MEN1KMT2AALDH1A1SMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877199-A ALZHEIMER'S DISEASE; SEDATIVE SANKYO COMPANY, LIMITED (JP) 1999-03-02 US disclosed
EP-0804416-A1 HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS SANKYO COMPANY LIMITED (JP) 1997-11-05 EP disclosed
WO-1996003377-A1 HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS SANKYO COMPANY, LIMITED (JP) 1996-02-08 WO disclosed